Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04590781
Title Safety and Efficacy of XmAb18087 ± Pembrolizumab in Advanced Merkel Cell Carcinoma or Extensive-stage Small Cell Lung Cancer
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Xencor, Inc.

Merkel cell carcinoma

lung small cell carcinoma


Pembrolizumab + XmAb18087


Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Recruiting Duarte California 91010 United States Details
USC/Norris Comprehensive Cancer Center Recruiting Los Angeles California 90033 United States Details
Dartmouth Hitchcock Medical Center Recruiting Lebanon New Hampshire 03756 United States Details
Memorial Sloan Kettering Recruiting New York New York 10065 United States Details
OU Health, Stephenson Cancer Center Recruiting Oklahoma City Oklahoma 73104 United States Details
Swedish Cancer Institute Recruiting Seattle Washington 98109 United States Details
University of Washington Recruiting Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from for the field